Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nutrients ; 15(22)2023 Nov 07.
Artículo en Inglés | MEDLINE | ID: mdl-38004100

RESUMEN

Skeletal muscle is the key tissue for maintaining protein and glucose homeostasis, having a profound impact on the development of diabetes. Diabetes causes deleterious changes in terms of loss of muscle mass, which will contribute to reduced glucose uptake and therefore progression of the disease. Nutritional approaches in diabetes have been directed to increase muscle glucose uptake, and improving protein turnover has been at least partially an oversight. In muscle, ß-hydroxy ß-methyl butyrate (HMB) promotes net protein synthesis, while arginine and lysine increase glucose uptake, albeit their effects on promoting protein synthesis are limited. This study evaluates if the combination of HMB, lysine, and arginine could prevent the loss of muscle mass and function, reducing the progression of diabetes. Therefore, the combination of these ingredients was tested in vitro and in vivo. In muscle cell cultures, the supplementation enhances glucose uptake and net protein synthesis due to an increase in the amount of GLUT4 transporter and stimulation of the insulin-dependent signaling pathway involving IRS-1 and Akt. In vivo, using a rat model of diabetes, the supplementation increases lean body mass and insulin sensitivity and decreases blood glucose and serum glycosylated hemoglobin. In treated animals, an increase in GLUT4, creatine kinase, and Akt phosphorylation was detected, demonstrating the synergic effects of the three ingredients. Our findings showed that nutritional formulations based on the combination of HMB, lysine, and arginine are effective, not only to control blood glucose levels but also to prevent skeletal muscle atrophy associated with the progression of diabetes.


Asunto(s)
Diabetes Mellitus , Lisina , Ratas , Animales , Lisina/farmacología , Lisina/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Glucemia/metabolismo , Arginina/farmacología , Arginina/metabolismo , Músculo Esquelético/metabolismo , Diabetes Mellitus/metabolismo , Glucosa/metabolismo , Insulina/metabolismo , Suplementos Dietéticos
2.
FEBS Lett ; 588(14): 2246-54, 2014 Jun 27.
Artículo en Inglés | MEDLINE | ID: mdl-24846141

RESUMEN

The balance between the rates of protein synthesis and degradation in muscle is regulated by PI3K/Akt signaling. Here we addressed the effect of ERK activation by sodium tungstate on protein turnover in rat L6 myotubes. Phosphorylation of ERK by this compound increased protein synthesis by activating MTOR and prevented dexamethasone-induced protein degradation by blocking FoxO3a activity, but it did not alter Akt phosphorylation. Thus, activation of ERK by tungstate improves protein turnover in dexamethasone-treated cells. On the basis of our results, we propose that tungstate be considered an alternative to IGF-I and its analogs in the prevention of skeletal muscle atrophy.


Asunto(s)
Sistema de Señalización de MAP Quinasas , Fibras Musculares Esqueléticas/metabolismo , Biosíntesis de Proteínas/efectos de los fármacos , Proteolisis/efectos de los fármacos , Compuestos de Tungsteno/farmacología , Animales , Dexametasona/farmacología , Evaluación Preclínica de Medicamentos , Activación Enzimática , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Proteína Forkhead Box O3 , Factores de Transcripción Forkhead/metabolismo , Glucocorticoides/farmacología , Proteínas de Choque Térmico/genética , Proteínas de Choque Térmico/metabolismo , Proteínas Asociadas a Microtúbulos/genética , Proteínas Asociadas a Microtúbulos/metabolismo , Fibras Musculares Esqueléticas/efectos de los fármacos , Atrofia Muscular/prevención & control , Complejo de la Endopetidasa Proteasomal/metabolismo , Ratas , Proteína Sequestosoma-1 , Serina-Treonina Quinasas TOR/metabolismo , Transcripción Genética/efectos de los fármacos , Ubiquitina/genética , Ubiquitina/metabolismo
3.
Clin Nutr ; 28(5): 565-74, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19477051

RESUMEN

BACKGROUND AND AIMS: To evaluate if the antidiabetic properties of Salacia oblonga extract are mediated not only by inhibiting intestinal alpha-glycosidases but also by enhancing glucose transport in muscle and adipose cells. METHODS: S. oblonga extract effects on 2-deoxy-D-glucose uptake were assayed in muscle L6-myotubes and 3T3-adipocytes. In L6-myotubes, the amount and translocation of glucose transporters were assayed. A fractionation of the extract was carried out to identify the active compounds. Furthermore, we analyzed the phosphorylation status of key components of signaling pathways that are involved in the molecular mechanisms regulating glucose uptake. RESULTS: S. oblonga extract increased 2-deoxy-D-glucose uptake by 50% in L6-myotubes and 3T3-adipocytes. In L6-myotubes, the extract increased up to a 100% the GLUT4 content, activating GLUT4 promoter transcription and its translocation to the plasma membrane. Mangiferin was identified as the bioactive compound. Furthermore, mangiferin effects were concomitant with the phosphorylation of 5'-AMP-activated protein kinase without the activation of PKB/Akt. The effect of mangiferin on 2-deoxy-D-glucose uptake was blocked by GW9662, an irreversible PPAR-gamma antagonist. CONCLUSIONS: S. oblonga extract and mangiferin may exert their antidiabetic effect by increasing GLUT4 expression and translocation in muscle cells. These effects are probably mediated through two independent pathways that are related to 5'-AMP-activated protein kinase and PPAR-gamma.


Asunto(s)
Transportador de Glucosa de Tipo 4/metabolismo , Hipoglucemiantes/farmacología , Fibras Musculares Esqueléticas/efectos de los fármacos , Extractos Vegetales/farmacología , Salacia/química , Xantonas/farmacología , Células 3T3 , Proteínas Quinasas Activadas por AMP/metabolismo , Animales , Línea Celular , Membrana Celular/efectos de los fármacos , Membrana Celular/enzimología , Membrana Celular/metabolismo , Desoxiglucosa/metabolismo , Relación Dosis-Respuesta a Droga , Transportador de Glucosa de Tipo 1/metabolismo , Transportador de Glucosa de Tipo 4/genética , Insulina/farmacología , Ratones , Fibras Musculares Esqueléticas/metabolismo , PPAR gamma/antagonistas & inhibidores , PPAR gamma/metabolismo , Extractos Vegetales/química , Raíces de Plantas/química , Ratas , Rosiglitazona , Tiazolidinedionas/farmacología , Xantonas/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA